U.S. Interactive Media and Services Stock News

If you are wondering whether Independence Realty Trust is attractively priced right now, you are not alone. This article focuses squarely on what you might be paying for each dollar of its fundamentals. The share price last closed at US$16.60, with returns of a 0.6% decline over 7 days, a 4.0% decline over 30 days, a 5.7% decline year to date and a 13.4% decline over 1 year, compared with a 34.4% gain over 5 years. These mixed return figures sit against a backdrop of ongoing interest in...

Patterson-UTI Energy (PTEN) just closed out FY 2025 with Q4 revenue of US$1.2b, a basic EPS loss of US$0.02, and net income excluding extra items at a loss of US$9.1m, while trailing twelve month figures show revenue of US$4.8b and a full year basic EPS loss of US$0.24. Over recent quarters the company has seen quarterly revenue move from US$1.4b in Q3 2024 to US$1.2b in Q4 2025, with basic EPS shifting from a loss of US$2.50 in Q3 2024 to a much smaller loss of US$0.02 in Q4 2025. This puts...

Black Hills Corp (NYSE:BKH) is in the discovery phase of a potential merger with NorthWestern Energy, with regulatory approvals still pending. The company is also accelerating its data center pipeline to more than 3 gigawatts, with interest from major technology firms including Meta and Microsoft. These developments could reshape how Black Hills allocates capital between traditional utility operations and power demand from large scale tech clients. Black Hills, trading at $72.3, has seen a...

Bassett Furniture Industries (BSET) has wrapped up FY 2025 with fourth quarter revenue of US$88.7 million and basic EPS of US$0.18, alongside net income of US$1.5 million. Trailing 12 month figures show revenue of US$335.3 million and EPS of US$0.70. The company has seen revenue move from US$84.3 million in Q4 FY 2024 to US$88.7 million in Q4 FY 2025, with basic EPS shifting from US$0.38 to US$0.18 over the same period, as trailing 12 month net income reached US$6.1 million. Overall, these...

What Cerence’s latest earnings and guidance mean for investors Cerence (CRNC) has drawn fresh attention after reporting first quarter results and updating its outlook, with revenue of US$115.08 million and a net loss of US$5.24 million from continuing operations. The company also issued guidance for the second quarter ending March 31, 2026, and reaffirmed its full year fiscal 2026 ranges, giving investors more concrete reference points for expectations around revenue, margins and...

Plains All American Pipeline (PAA) closed out FY 2025 with Q4 revenue of US$10.6b and basic EPS of US$0.34, capping a year in which trailing twelve month EPS reached US$1.49 on revenue of US$44.3b. Over the last few quarters, the company has seen revenue move from US$12.4b and EPS of US$0.06 in Q3 2024 to US$11.6b and EPS of US$0.44 in Q3 2025 before landing at the latest Q4 run rate. This gives investors a clearer view of how the earnings base has been building. With trailing net profit...

NetScout Systems launched upgraded nGeniusONE observability features that support Wi Fi 7 and advanced SSL/TLS certificate management. The release targets remote site monitoring, digital resilience, and cybersecurity needs for enterprises using hybrid and cloud environments. The company highlights these tools as a way to reduce outage risk, address certificate issues earlier, and support compliance efforts. For investors watching NasdaqGS:NTCT, the product update comes with the stock...

If you are wondering whether Pinnacle West Capital's share price still offers fair value or is starting to look stretched, you are not alone. The stock last closed at US$93.52, with returns of 7.0% over 30 days, 6.1% year to date, 11.9% over 1 year, 43.5% over 3 years, and 53.1% over 5 years. This naturally raises questions about what is already priced in. Recent coverage around Pinnacle West Capital has focused on its position as a regulated utility and how investors view its role as a...

Qualys (QLYS) just wrapped up FY 2025 with Q4 total revenue of US$175.3 million and basic EPS of US$1.48, setting the tone for how the full year’s profitability story reads. Over the past six quarters, revenue has moved from US$153.9 million in Q3 2024 to US$175.3 million in Q4 2025, while quarterly basic EPS shifted from US$1.26 to US$1.48 over the same window. This gives investors a clear view of the recent trend in top line and per share earnings. With trailing twelve month net income at...

BARK (BARK) has released its Q3 2026 results, reporting revenue of US$98.4 million and a net loss of US$8.6 million, equal to basic EPS of a US$0.05 loss, as investors watch how its subscription pet products story holds up. The company has seen quarterly revenue move from US$126.4 million in Q3 2025 to US$115.4 million in Q4 2025, US$102.9 million in Q1 2026, US$107.0 million in Q2 2026 and US$98.4 million in Q3 2026. Over the same period, basic EPS losses have ranged between US$0.03 and...

Lesaka Technologies (NasdaqGS:LSAK) has reported Q2 2026 results that keep the focus firmly on revenue scale and ongoing losses, with quarterly revenue at US$171.4 million and EPS at a loss of US$0.05, while trailing 12 month figures show revenue of US$677.6 million and a net loss of US$84.3 million, or EPS of US$1.08 in losses. Over recent quarters, the company has seen revenue move from US$146.0 million in Q4 2024 to US$153.6 million in Q1 2025, US$146.8 million in Q2 2025, US$135.7 million...

Vita Coco Company (NasdaqGS:COCO) is being highlighted for its role as a global leader in functional hydration, supported by a flexible, scalable business model. Recent coverage explored how new tax rules that favor business investment could influence Vita Coco's future capital deployment and expansion plans. Co Founder Mike Kirban shared insights on brand building, competing against larger beverage players, and key milestones such as the company's IPO. Vita Coco operates in the functional...

Exponent (NasdaqGS:EXPO) reported robust fourth quarter results with revenue growth and solid business momentum. The company announced an increase to its regular cash dividend, signaling a more shareholder focused capital return profile. Management highlighted new uses of artificial intelligence in both client work and internal operations as a key development. Exponent, a science and engineering consulting firm, sits at the intersection of technical expertise and real world problem solving...

Pathward Financial (CASH) just posted its Q1 2026 scorecard, with total revenue at US$169.9 million and basic EPS of US$1.57 setting the tone for how the quarter landed. Over recent periods, the company has seen quarterly revenue move from US$169.9 million in Q4 2024 to US$163.97 million in Q1 2025, and then to US$169.9 million in Q1 2026. Basic EPS has shifted from US$1.34 to US$1.23 and now US$1.57, giving investors a clear line of sight on how the top and bottom lines are tracking into...

Virtus Investment Partners (NYSE:VRTS) is expanding into private markets through a majority stake in Keystone National Group and a minority investment in Crescent Cove. The firm is also launching new actively managed ETFs as it adjusts its product lineup alongside recent equity outflows. These moves reshape Virtus Investment Partners' business mix beyond its traditional equity focused strategies. For investors watching NYSE:VRTS, the timing of these steps comes after a period of weaker...

If you are wondering whether Ardent Health's current share price reflects its real worth, this article will walk you through what the numbers are saying about value. The stock last closed at US$8.58, with a 4.1% return over the past 7 days, a 7.9% decline over the last 30 days, and a 0.7% decline year to date, compared with a 42.3% decline over the past year. Recent news flow around Ardent Health has largely centered on its position within the US healthcare sector and how investors are...

Gorman-Rupp (NYSE:GRC) reported record net sales, net income, and incoming orders for the full year 2025. The company outlined operational optimization efforts that are expected to bring cost savings and support improved profitability over time. The update highlights both financial performance and changes to the company’s operating footprint that are important for shareholders to monitor. For investors tracking NYSE:GRC, the latest update comes with the stock at $59.55 and a reported 60.4%...

PAR Technology (NYSE:PAR) has expanded its partnership with Jack’s Family Restaurants, which will roll out a unified platform for point of sale, payments, loyalty, and hardware across about 300 locations. The company has also broadened its integrations with workforce management provider Netchex, linking restaurant operations more tightly with payroll and HR systems for multi location operators. PAR Technology is leaning into its role as a full stack restaurant tech provider at a time when...

Winnebago Industries, Inc. recently announced it will redeem US$100,000,000 of its US$200,000,000 6.250% Senior Secured Notes due 2028 on February 20, 2026, at 100% of principal plus accrued and unpaid interest. This partial redemption highlights the company’s emphasis on balance sheet strength and financial flexibility, using available cash to reduce secured debt. Next, we’ll examine how this move to cut higher-cost secured debt influences Winnebago Industries’ broader investment...

BML Capital Management has exited its entire position in Alumis (NasdaqGS:ALMS). The move aligns with Alumis filing a new shelf registration. The company is also preparing to appear at several major investor conferences. BML Capital Management stepping away from Alumis puts fresh attention on how the market views the biotech name. Alumis, which focuses on drug development, now heads into a period where it is updating its capital markets toolkit through a shelf registration while also...

To the annoyance of some shareholders, Doximity, Inc. ( NYSE:DOCS ) shares are down a considerable 27% in the last...

UiPath, Inc. ( NYSE:PATH ) shares have had a horrible month, losing 30% after a relatively good period beforehand. The...

FDA accepts Exelixis' New Drug Application for zanzalintinib plus atezolizumab in metastatic colorectal cancer. The application is based on pivotal trial data for patients with advanced disease. This step moves the investigational combination closer to potential commercial use in the United States. For investors watching NasdaqGS:EXEL, this FDA filing milestone is an important datapoint in the company’s oncology pipeline. Exelixis focuses on cancer therapies, and colorectal cancer is a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...